← FDA DRUG APPROVALS

FDA ANDA · ANDA200271

HYDROXYPROGESTERONE CAPROATE

Sponsor: ASPEN GLOBAL INC

APPLICATION
ANDA200271
TYPE
ANDA
ORIGINAL APPROVAL
2015-08-24
LATEST ACTION
2015-08-24
ROUTE
INTRAMUSCULAR
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

HYDROXYPROGESTERONE CAPROATEDiscontinued
HYDROXYPROGESTERONE CAPROATE 1250MG/5ML (250MG/ML) · SOLUTION · INTRAMUSCULAR

Approval history

2015-08-24Not Applicable · OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →